[HTML][HTML] Activation of c-MET induces a stem-like phenotype in human prostate cancer

…, R Sookhlall, WJ Teubel, CMA de Ridder, S Reneman… - PloS one, 2011 - journals.plos.org
Prostate cancer consists of secretory cells and a population of immature cells. The function
of immature cells and their mutual relation with secretory cells are still poorly understood. …

[HTML][HTML] A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues

RPJ Schroeder, C Müller, S Reneman, ML Melis… - European journal of …, 2010 - Springer
Purpose Prostate-specific antigen (PSA)-based screening for prostate cancer (PC) has
dramatically increased early diagnosis. Current imaging techniques are not optimal to stage early …

Androgen-dependent expression of the gastrin-releasing peptide receptor in human prostate tumor xenografts

…, CMA de Ridder, S Reneman… - Journal of Nuclear …, 2007 - Soc Nuclear Med
Human prostate cancers (PC) overexpress gastrin-releasing peptide (GRP) receptors. This
observation suggests that GRP receptors may be used as new visualization and treatment …

[HTML][HTML] Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of …

…, CH Grievink-de Ligt, HC Groen, S Reneman… - European journal of …, 2011 - Springer
Purpose Prostate cancer (PC) is a major health problem. Overexpression of the gastrin-releasing
peptide receptor (GRPR) in PC, but not in the hyperplastic prostate, provides a …

Androgen‐regulated gastrin‐releasing peptide receptor expression in androgen‐dependent human prostate tumor xenografts

…, CMA de Ridder, S Reneman… - … journal of cancer, 2010 - Wiley Online Library
Human prostate cancer (PC) overexpresses the gastrin‐releasing peptide receptor (GRPR).
Radiolabeled GRPR‐targeting analogs of bombesin (BN) have successfully been …

Profiling of antibody production against xenograft-released proteins by protein microarrays discovers prostate cancer markers

…, WM van Weerden, S Reneman… - Journal of proteome …, 2012 - ACS Publications
This study describes a novel xenograft-based biomarker discovery platform and proves its
usefulness in the discovery of serum markers for prostate cancer. By immunizing immuno-…

[HTML][HTML] A prostate cancer vaccine comprising whole cells secreting IL-7, effective against subcutaneous challenge, requires local GM-CSF for intra-prostatic efficacy

C Schroten-Loef, CMA de Ridder, S Reneman… - Cancer immunology …, 2009 - Springer
A panel of cytokine-secreting RM-9 prostate cancer cells were tested as whole cell vaccines
to determine their capacity to evoke an anti-prostate cancer immune response. In our model, …

[HTML][HTML] Renal uptake of different radiolabelled peptides is mediated by megalin: SPECT and biodistribution studies in megalin-deficient mice

E Vegt, M Melis, A Eek, M de Visser, M Brom… - European journal of …, 2011 - Springer
Purpose Radiolabelled peptides used for peptide receptor radionuclide therapy are excreted
mainly via the kidneys and are partly reabsorbed and retained in the proximal tubular cells. …

The human PC346 xenograft and cell line panel: a model system for prostate cancer progression

RB Marques, WM van Weerden, S Erkens-Schulze… - European urology, 2006 - Elsevier
… Hein van der Poel for the ASO hybridization, and Denie Zonruiter and Suzanne
Reneman for biotechnical assistance in the animal care and propagation of the xenografts. …

Prevascular structures promote vascularization in engineered human adipose tissue constructs upon implantation

F Verseijden, SJPV Sluijs, E Farrell… - Cell …, 2010 - journals.sagepub.com
Vascularization is still one of the most important limitations for the survival of engineered
tissues after implantation. In this study, we aim to improve the in vivo vascularization of …